That's a tricky situation, and it makes sense that your oncologist wants to think carefully about combining treatments. If Hydrea (hydroxyurea) needs to be stopped, there are other cytoreductive therapy options that may work well for managing ET.
Some alternatives your care team might consider include:
- Interferon Show Full Answer
That's a tricky situation, and it makes sense that your oncologist wants to think carefully about combining treatments. If Hydrea (hydroxyurea) needs to be stopped, there are other cytoreductive therapy options that may work well for managing ET.
Some alternatives your care team might consider include:
- Interferon therapies (such as Besremi or Pegasys)
- Ruxolitinib (Jakafi) — a JAK inhibitor
- Anagrelide (Agrylin)
Each option has its own benefits and potential risks, so the right choice will depend on your individual situation, including your risk level and symptom profile. It's really important to make sure both your oncologist and the doctor managing your RA treatment are communicating with each other. Having a coordinated care plan will help ensure that whatever is chosen keeps your ET well-managed while also addressing your other needs.
Don't hesitate to ask your oncologist directly about which alternative they feel is the safest and most effective option for your specific case. Being open about your treatment goals and quality of life concerns can really help guide those conversations.
July 17
Join
Your Privacy Choices
